Literature DB >> 10069628

The composition of serous fluid after axillary dissection.

J Bonnema1, D A Ligtenstein, T Wiggers, A N van Geel.   

Abstract

OBJECTIVE: To analyse the composition of the serous fluid formed after axillary dissection.
DESIGN: Descriptive study.
SETTING: University hospital and teaching hospital, The Netherlands.
SUBJECTS: 16 patients whose axillas were dissected as part of a modified radical mastectomy for stage I or II breast cancer. MAIN OUTCOME MEASURES: Chemical and cellular composition of axillary drainage fluid on the first, fifth, and tenth postoperative days compared with the same constituents in blood and with reported data on the composition of peripheral lymph. RESULTS AND
CONCLUSION: On the first postoperative day the drainage fluid contained blood contents and a high concentration of creatine phosphokinase (CPK). After day one it changed to a peripheral lymph-like fluid but containing different cells, more protein, and no fibrinogen, making coagulation impossible. The reduction in the fluid production must be caused by other wound healing processes, such as formation of scars and connective tissue.

Entities:  

Mesh:

Year:  1999        PMID: 10069628     DOI: 10.1080/110241599750007441

Source DB:  PubMed          Journal:  Eur J Surg        ISSN: 1102-4151


  11 in total

1.  Comparison Study Between Scalpel and Electrocautery, in Causation of Seroma After Modified Radical Mastectomy.

Authors:  Rahulkumar N Chavan; Bhargav Chikkala; Pranab Mondal; Diptendra Kumar Sarkar
Journal:  Indian J Surg       Date:  2016-05-14       Impact factor: 0.656

2.  Postmortem quantitative 1.5-T MRI for the differentiation and characterization of serous fluids, blood, CSF, and putrefied CSF.

Authors:  Wolf-Dieter Zech; Nicole Schwendener; Anders Persson; Marcel J Warntjes; Fabiano Riva; Frederick Schuster; Christian Jackowski
Journal:  Int J Legal Med       Date:  2015-07-11       Impact factor: 2.686

3.  The Use of TissuGlu® Surgical Adhesive for Mastectomy With or Without Lymphonodectomy.

Authors:  Ralf Ohlinger; Leonie Gieron; Rico Rutkowski; Thomas Kohlmann; Marek Zygmunt; Julia Unger
Journal:  In Vivo       Date:  2018 May-Jun       Impact factor: 2.155

4.  Does LigaSure reduce fluid drainage in axillary dissection? A randomized prospective clinical trial.

Authors:  M Antonio; T Pietra; Lg Domenico; D Massimo; R Ignazio; N Antonio; C Luigi
Journal:  Ecancermedicalscience       Date:  2007-11-29

5.  Surgical resection and scarification for chronic seroma post-ventral hernia mesh repair.

Authors:  Vasileios Vasilakis; Kristin Cook; Dorian Wilson
Journal:  Am J Case Rep       Date:  2014-11-28

6.  Effectiveness of Cyanoacrylate in Reducing Seroma Formation in Breast Cancer Patients Post-Axillary Dissection: A Randomized Controlled Trial.

Authors:  Mahmoud Al-Masri; Fade Alawneh; Faiez Daoud; Ali Ebous; Basem Hamdan; Hani Al-Najjar; Rama Al-Masri; Marwan Abu Farah
Journal:  Front Oncol       Date:  2021-01-25       Impact factor: 6.244

7.  Axillary dissection in primary breast cancer: variations of the surgical technique and influence on morbidity.

Authors:  Sebastian Wojcinski; Sirin Nuengsri; Peter Hillemanns; Werner Schmidt; Mustafa Deryal; Kubilay Ertan; Friedrich Degenhardt
Journal:  Cancer Manag Res       Date:  2012-04-27       Impact factor: 3.989

8.  Seroma formation after breast cancer surgery: what we have learned in the last two decades.

Authors:  Vivek Srivastava; Somprakas Basu; Vijay Kumar Shukla
Journal:  J Breast Cancer       Date:  2012-12-31       Impact factor: 3.588

9.  Surgical resection for persistent seroma, following modified radical mastectomy.

Authors:  Marek Stanczyk; Bartlomiej Grala; Tomasz Zwierowicz; Marek Maruszynski
Journal:  World J Surg Oncol       Date:  2007-09-23       Impact factor: 2.754

10.  Recurrent late seroma after immediate breast reconstruction with latissimus dorsi musculocutaneous flap.

Authors:  Seong Hwan Bae; Yong Woo Lee; Su Bong Nam; So Jeong Lee; Heeseung Park; Taewoo Kang
Journal:  Arch Plast Surg       Date:  2020-04-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.